144 related articles for article (PubMed ID: 32612862)
1. Intestinal Perforation due to Neutropenic Enterocolitis in a Patient Treated with Bevacizumab for Ovarian Cancer.
Sasaki A; Harano K; Kogawa T; Matsubara N; Naito Y; Hosono A; Mukai H; Yoshino T; Mukohara T
Case Rep Oncol Med; 2020; 2020():7231358. PubMed ID: 32612862
[TBL] [Abstract][Full Text] [Related]
2. Neutropenic enterocolitis-induced sepsis and disseminated intravascular coagulation after chemotherapy: a case report.
Ishikawa M; Nakayama K; Razia S; Ishida A; Yamashita H; Ishibashi T; Sato S; Sawada K; Sasamori H; Kurose S; Ishikawa N; Kyo S
BMC Womens Health; 2021 May; 21(1):187. PubMed ID: 33941182
[TBL] [Abstract][Full Text] [Related]
3. Bevacizumab-induced intestinal perforation in a patient with inoperable breast cancer: a case report and review of the literature.
Fujii Y; Hirahara N; Kaji S; Taniura T; Hyakudomi R; Yamamoto T; Tajima Y
J Med Case Rep; 2018 Mar; 12(1):84. PubMed ID: 29580267
[TBL] [Abstract][Full Text] [Related]
4. A phase II clinical trial of pegylated liposomal doxorubicin and carboplatin plus bevacizumab in patients with platinum-sensitive recurrent ovarian, fallopian tube, or primary peritoneal cancer.
del Carmen MG; Micha J; Small L; Street DG; Londhe A; McGowan T
Gynecol Oncol; 2012 Sep; 126(3):369-74. PubMed ID: 22659190
[TBL] [Abstract][Full Text] [Related]
5. [Two Cases of Bowel Perforation during Chemotherapy with Bevacizumab to Metastatic Rectal Cancer].
Miyake Y; Ikeda K; Murakami M; Oka Y; Nezu R; Kurokawa E; Kikkawa N
Gan To Kagaku Ryoho; 2015 Dec; 42 Suppl 1():75-8. PubMed ID: 26809419
[TBL] [Abstract][Full Text] [Related]
6. Neutropenic colitis with cecal perforation during antithyroid therapy.
Chen DF; Chao IM; Huang SH
J Formos Med Assoc; 2003 Sep; 102(9):644-6. PubMed ID: 14625610
[TBL] [Abstract][Full Text] [Related]
7. Rectal perforation following paclitaxel and carboplatin chemotherapy for advanced ovarian cancer: a case report and review of the literature.
Jayakody S; Wright DB; Chiong C; Liu M; Bouffler C; El-Khoury T
J Med Case Rep; 2018 Aug; 12(1):221. PubMed ID: 30111379
[TBL] [Abstract][Full Text] [Related]
8. Neutropenic enterocolitis in a patient with ovarian cancer after treatment with high-dose carboplatin and granulocyte macrophage-colony stimulating factor (GM-CSF).
Vlasveld LT; Ten Bokkel Huinink WW; Rodenhuis S
Neth J Med; 1990 Oct; 37(3-4):158-61. PubMed ID: 2250761
[TBL] [Abstract][Full Text] [Related]
9. Neutropenic enterocolitis in an advanced epithelial ovarian cancer patient treated with paclitaxel/platinum-based chemotherapy: a case report and review of the literature.
Gadducci A; Gargini A; Palla E; Fanucchi A; Genazzani AR
Anticancer Res; 2005; 25(3c):2509-13. PubMed ID: 16080485
[TBL] [Abstract][Full Text] [Related]
10. [A Case of Fournier's Gangrene Caused by Small Intestinal Perforation during Bevacizumab Combination Chemotherapy].
Ishida T; Shinozaki H; Ozawa H; Kobayashi T; Kato S; Wakabayashi T; Matsumoto K; Sasakura Y; Shimizu T; Terauchi T; Kimata M; Furukawa J; Kobayashi K; Ogata Y
Gan To Kagaku Ryoho; 2016 Jul; 43(7):909-11. PubMed ID: 27431640
[TBL] [Abstract][Full Text] [Related]
11. Selective management of patients with neutropenic enterocolitis using peritoneal lavage.
Sauter ER; Vauthey JN; Bolton JS; Sardi A
J Surg Oncol; 1990 Sep; 45(1):63-7. PubMed ID: 2381215
[TBL] [Abstract][Full Text] [Related]
12. Good functional outcome following severe neutropenic enterocolitis and perforation in a 48-year-old woman undergoing chemotherapy for breast cancer.
Fenton R; Schneiders H; Reid J
BMJ Case Rep; 2021 Mar; 14(3):. PubMed ID: 33653834
[TBL] [Abstract][Full Text] [Related]
13. Neutropenic enterocolitis affecting the transverse colon: an unusual complication of chemotherapy.
Ramsingh J; Bolln C; Hodnett R; Al-Ani A
BMJ Case Rep; 2014 May; 2014():. PubMed ID: 24792023
[TBL] [Abstract][Full Text] [Related]
14. FDA drug approval summary: bevacizumab (Avastin) plus Carboplatin and Paclitaxel as first-line treatment of advanced/metastatic recurrent nonsquamous non-small cell lung cancer.
Cohen MH; Gootenberg J; Keegan P; Pazdur R
Oncologist; 2007 Jun; 12(6):713-8. PubMed ID: 17602060
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety results from OCTAVIA, a single-arm phase II study evaluating front-line bevacizumab, carboplatin and weekly paclitaxel for ovarian cancer.
Gonzalez-Martin A; Gladieff L; Tholander B; Stroyakovsky D; Gore M; Scambia G; Kovalenko N; Oaknin A; Ronco JP; Freudensprung U; Pignata S;
Eur J Cancer; 2013 Dec; 49(18):3831-8. PubMed ID: 24007819
[TBL] [Abstract][Full Text] [Related]
16. Neutropenic Enterocolitis Disclosing an Underlying Cyclic Neutropenia.
Lahlimi FE; Khalil K; Lahiaouni S; Tazi I
Case Rep Pediatr; 2020; 2020():8858764. PubMed ID: 33343958
[TBL] [Abstract][Full Text] [Related]
17. Intestinal Perforation: A Rare Complication of Treatment With Bevacizumab.
Adhikari R; Ghose M; Tekin A; Singh S; Singh R
Cureus; 2021 Mar; 13(3):e14093. PubMed ID: 33907639
[TBL] [Abstract][Full Text] [Related]
18. [A Case of Duodenal Perforation during Bevacizumab Combination Chemotherapy in a Patient with Multiple Lung Metastasis after a Sigmoidectomy].
Suzumura H; Shinozaki H; Kondo R; Yamaguchi M; Torizaki Y; Ozawa Y; Futoh Y; Matsuoka T; Matsumoto K; Inoue M; Sasakura Y; Terauchi T; Kimata M; Furukawa J; Kobayashi K; Ogata Y
Gan To Kagaku Ryoho; 2019 May; 46(5):953-955. PubMed ID: 31189824
[TBL] [Abstract][Full Text] [Related]
19. Bevacizumab, Carboplatin and Paclitaxel Combination Treatment in Advanced Stage Ovarian Cancer: The First Experience in Thammasat University Hospital, Thailand: A Case Report.
Suwannarurk K; Thaweekul Y; Mairaing K; Poomtavorn Y; Tangtiang K; Piyawang W; Bhamarapravatana K
J Med Assoc Thai; 2015 Apr; 98 Suppl 3():S121-5. PubMed ID: 26387399
[TBL] [Abstract][Full Text] [Related]
20. Subserous invasion of VEGF-C-producing cancer cells is a possible risk factor for ileal ulceration in the non-metastatic mucosal layer during bevacizumab-combined chemotherapy for recurrent ovarian cancer: A case report.
Matsumoto T; Mizumoto Y; Nakade K; Obata T; Matsuoka A; Myojo S; Ono M; Nakamura M; Fujiwara H
Mol Clin Oncol; 2017 Nov; 7(5):820-824. PubMed ID: 29181171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
